WO1998033808A3 - A reversible stoichiometric process for conjugating biomolecules - Google Patents

A reversible stoichiometric process for conjugating biomolecules Download PDF

Info

Publication number
WO1998033808A3
WO1998033808A3 PCT/US1998/002007 US9802007W WO9833808A3 WO 1998033808 A3 WO1998033808 A3 WO 1998033808A3 US 9802007 W US9802007 W US 9802007W WO 9833808 A3 WO9833808 A3 WO 9833808A3
Authority
WO
WIPO (PCT)
Prior art keywords
reversible
stoichiometric process
conjugating biomolecules
conjugating
biomolecules
Prior art date
Application number
PCT/US1998/002007
Other languages
French (fr)
Other versions
WO1998033808A2 (en
Inventor
Hubert Koster
Original Assignee
Hubert Koster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubert Koster filed Critical Hubert Koster
Priority to AU61416/98A priority Critical patent/AU748806B2/en
Priority to JP53319598A priority patent/JP2001526776A/en
Priority to EP98906096A priority patent/EP1000081A2/en
Priority to CA002284463A priority patent/CA2284463A1/en
Priority to DE19882066T priority patent/DE19882066T1/en
Publication of WO1998033808A2 publication Critical patent/WO1998033808A2/en
Publication of WO1998033808A3 publication Critical patent/WO1998033808A3/en
Priority to NO993746A priority patent/NO993746L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes

Abstract

Compositions comprised of at least two biopolymers (e.g., nucleic acids or polypeptides), which are conjugated to an insoluble support by two different reversible linkages, which are cleavable under selective conditions, as well as methods and components for producing the same are described.
PCT/US1998/002007 1997-02-04 1998-02-04 A reversible stoichiometric process for conjugating biomolecules WO1998033808A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU61416/98A AU748806B2 (en) 1997-02-04 1998-02-04 A reversible stoichiometric process for conjugating biomolecules
JP53319598A JP2001526776A (en) 1997-02-04 1998-02-04 Reversible stoichiometric process for binding biomolecules
EP98906096A EP1000081A2 (en) 1997-02-04 1998-02-04 A reversible stoichiometric process for conjugating biomolecules
CA002284463A CA2284463A1 (en) 1997-02-04 1998-02-04 A reversible stoichiometric process for conjugating biomolecules
DE19882066T DE19882066T1 (en) 1997-02-04 1998-02-04 Reversible stoichiometric method for conjugating biomolecules
NO993746A NO993746L (en) 1997-02-04 1999-08-03 A reversible, stoichiometric process for biomolecule conjugation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3716597P 1997-02-04 1997-02-04
US60/037,165 1997-02-04

Publications (2)

Publication Number Publication Date
WO1998033808A2 WO1998033808A2 (en) 1998-08-06
WO1998033808A3 true WO1998033808A3 (en) 1999-02-25

Family

ID=21892797

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/002007 WO1998033808A2 (en) 1997-02-04 1998-02-04 A reversible stoichiometric process for conjugating biomolecules

Country Status (7)

Country Link
EP (1) EP1000081A2 (en)
JP (1) JP2001526776A (en)
AU (1) AU748806B2 (en)
CA (1) CA2284463A1 (en)
DE (1) DE19882066T1 (en)
NO (1) NO993746L (en)
WO (1) WO1998033808A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9034798B2 (en) 2003-01-16 2015-05-19 Caprotec Bioanalytics Gmbh Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
US9249456B2 (en) 2004-03-26 2016-02-02 Agena Bioscience, Inc. Base specific cleavage of methylation-specific amplification products in combination with mass analysis
US9394565B2 (en) 2003-09-05 2016-07-19 Agena Bioscience, Inc. Allele-specific sequence variation analysis

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225061B1 (en) 1999-03-10 2001-05-01 Sequenom, Inc. Systems and methods for performing reactions in an unsealed environment
US20020009394A1 (en) 1999-04-02 2002-01-24 Hubert Koster Automated process line
US7917301B1 (en) 2000-09-19 2011-03-29 Sequenom, Inc. Method and device for identifying a biological sample
US20020155587A1 (en) 2001-04-20 2002-10-24 Sequenom, Inc. System and method for testing a biological sample
WO2003092581A2 (en) * 2001-07-16 2003-11-13 Hk Pharmaceuticals, Inc. Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
WO2019081680A1 (en) * 2017-10-25 2019-05-02 Institut Pasteur Immobilization of nucleic acids using an enzymatic his-tag mimic for diagnostic applications

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004674A1 (en) * 1984-04-05 1985-10-24 Life Technologies, Inc. Immobilization of nucleic acids
DE3644346A1 (en) * 1986-12-19 1987-05-21 Saeulentechnik Dr Ing Herbert Matrix-bound crown ether ligands as separating material in the affinity chromatography of nucleic acids
WO1989005616A1 (en) * 1987-12-24 1989-06-29 Bio-Metric Systems, Inc. Biocompatible coatings
WO1990001564A1 (en) * 1988-08-09 1990-02-22 Microprobe Corporation Methods for multiple target analyses through nucleic acid hybridization
US5410068A (en) * 1989-10-23 1995-04-25 Perseptive Biosystems, Inc. Succinimidyl trityl compounds and a process for preparing same
US5547835A (en) * 1993-01-07 1996-08-20 Sequenom, Inc. DNA sequencing by mass spectrometry
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
WO1998020020A2 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. High density immobilization of nucleic acids

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004674A1 (en) * 1984-04-05 1985-10-24 Life Technologies, Inc. Immobilization of nucleic acids
DE3644346A1 (en) * 1986-12-19 1987-05-21 Saeulentechnik Dr Ing Herbert Matrix-bound crown ether ligands as separating material in the affinity chromatography of nucleic acids
WO1989005616A1 (en) * 1987-12-24 1989-06-29 Bio-Metric Systems, Inc. Biocompatible coatings
WO1990001564A1 (en) * 1988-08-09 1990-02-22 Microprobe Corporation Methods for multiple target analyses through nucleic acid hybridization
US5410068A (en) * 1989-10-23 1995-04-25 Perseptive Biosystems, Inc. Succinimidyl trityl compounds and a process for preparing same
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5547835A (en) * 1993-01-07 1996-08-20 Sequenom, Inc. DNA sequencing by mass spectrometry
WO1998020020A2 (en) * 1996-11-06 1998-05-14 Sequenom, Inc. High density immobilization of nucleic acids

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ARSHADY E: "BEADED POLYMER SUPPORTS AND GELS II. PHYSICO-CHEMICAL CRITERIA AND FUNCTIONALIZATION", JOURNAL OF CHROMATOGRAPHY, vol. 586, no. 2, 22 November 1991 (1991-11-22), pages 199 - 219, XP000247969 *
P.D.GERSHON ET AL.: "Stable Chelating Linkage for Reversible Immobilization of Oligohistidine Tagged Proteins in the BIAcore Surface Plasmon Resonance Detector.", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 183, 1995, pages 65 - 76, XP002081778 *
PON R T ET AL: "DERIVATIZATION OF CONTROLLED PORE GLASS BEADS FOR SOLID PHASE OLIGONUCLEOTIDE SYNTHESIS", BIOTECHNIQUES, vol. 6, no. 8, 1 January 1988 (1988-01-01), pages 768 - 770, 773 - 775, XP000562920 *
SCOUTEN W H ET AL: "REVERSIBLE IMMOBILIZATION OF ANTIBODIES ON MAGNETIC BEADS", ANALYTICAL BIOCHEMISTRY, vol. 205, no. 2, 1 September 1992 (1992-09-01), pages 313 - 318, XP000296795 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034798B2 (en) 2003-01-16 2015-05-19 Caprotec Bioanalytics Gmbh Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
US9394565B2 (en) 2003-09-05 2016-07-19 Agena Bioscience, Inc. Allele-specific sequence variation analysis
US9249456B2 (en) 2004-03-26 2016-02-02 Agena Bioscience, Inc. Base specific cleavage of methylation-specific amplification products in combination with mass analysis
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9096652B2 (en) 2008-05-13 2015-08-04 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Also Published As

Publication number Publication date
AU748806B2 (en) 2002-06-13
NO993746L (en) 1999-10-01
JP2001526776A (en) 2001-12-18
AU6141698A (en) 1998-08-25
CA2284463A1 (en) 1998-08-06
DE19882066T1 (en) 2000-01-05
EP1000081A2 (en) 2000-05-17
NO993746D0 (en) 1999-08-03
WO1998033808A2 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
CA2331337A1 (en) Site specific protein modification by mutagenesis
WO1999041273A3 (en) Pna and dna conjugates and methods for preparation thereof
WO1998033808A3 (en) A reversible stoichiometric process for conjugating biomolecules
NO992167L (en) Preparations and Methods for Immobilizing Nucleic Acids to Solid Carriers
CA2355379A1 (en) Compact material pusher with universal design and method of manufacture
WO2000012587A8 (en) Polyamide chains of precise length, methods to manufacture them and their conjugates
WO2005050171A3 (en) Methods and compositions relating to single reactive center reagents
CA2215933A1 (en) Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
DE60034566D1 (en) PEPTIDE RECEPTOR LIGATION PROCEDURE
WO2000046069A3 (en) Ignition enhanced gas generant and method
EP1102787A4 (en) 2'-o-aminoethyloxyethyl-modified oligonucleotides
AU5773798A (en) Pegylation process
SI1305329T2 (en) 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
CA2248006A1 (en) Activated linkers and methods for making and purifying the same
WO2002042418A3 (en) 3-hydroxypropionic acid and other organic compounds
CA2249061A1 (en) Protein production process
WO2002062999A8 (en) Proteins and nucleic acids encoding same
EP0939124A3 (en) MGBP1 sequences
AU4854999A (en) Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule
WO2004050710A3 (en) Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups
AU5729296A (en) Soluble, cleavable substrates of the hepatitis c virus prote ase
AU2253100A (en) Compositions obtained from (mangifera indica l.)
NL191466C (en) Al-Ti based alloy as well as process for its preparation.
WO2000020357A3 (en) Chemical constructs
EP0879888A3 (en) Patched-2 polypeptides and polynucleotides and methods for their production

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2284463

Country of ref document: CA

Ref document number: 2284463

Country of ref document: CA

Kind code of ref document: A

Ref document number: 1998 533195

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1998906096

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 61416/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 09355705

Country of ref document: US

RET De translation (de og part 6b)

Ref document number: 19882066

Country of ref document: DE

Date of ref document: 20000105

WWE Wipo information: entry into national phase

Ref document number: 19882066

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 1998906096

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 61416/98

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1998906096

Country of ref document: EP